enGene Holdings Inc. - Common Shares (ENGN)

Historical Holders from Q4 2023 to Q3 2025

Type / Class
Equity / Common Shares
Symbol
ENGN on Nasdaq
Shares outstanding
64,534,111
Price per share
$6.83
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
40,868,497
Total reported value
$279,131,773
% of total 13F portfolios
0%
Share change
+448,012
Value change
+$5,402,489
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of enGene Holdings Inc. - Common Shares (ENGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 10% $47,123,411 6,770,605 Perceptive Advisors LLC 11 Nov 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% $20,185,656 5,046,414 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
Kynam Capital Management, LP 9.8% $19,976,360 4,994,090 Kynam Capital Management, LP 31 Dec 2024
Deep Track Capital, LP 6.7% +58% $30,048,631 +$14,462,734 4,317,332 +93% Deep Track Capital, LP 11 Nov 2025
Fonds de solidarite des travailleurs et des travailleuses du Quebec 4.5% $8,119,004 2,029,751 Fonds de solidarite des travailleurs et des travailleuses du Quebec 30 Sep 2024
Adage Capital Management, L.P. 3% $6,115,072 1,528,768 Adage Capital Management, L.P. 31 Dec 2024
BIOTECHNOLOGY VALUE FUND L P 1.8% -68% $3,781,608 -$8,424,148 945,402 -69% BVF PARTNERS L P/IL 27 Jan 2025
As of 30 Sep 2025, enGene Holdings Inc. - Common Shares (ENGN) has 38 institutional shareholders filing 13F forms. They hold 40,868,497 shares. of 64,534,111 outstanding shares (63%) .

Top 25 institutional shareholders own 63% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FCPM III SERVICES B.V. 15% 9,632,561 0% 13% $65,790,391
VR ADVISER, LLC 7.8% 5,046,414 0% 1.9% $34,467,008
Kynam Capital Management, LP 7.7% 4,994,090 0% 2.5% $34,109,635
Blue Owl Capital Holdings LP 5.1% 3,278,106 -12% 7% $22,389,464
Cormorant Asset Management, LP 3.6% 2,323,595 0% 1.1% $15,870,154
BRAIDWELL LP 3.5% 2,266,319 0.46% $15,478,959
Deep Track Capital, LP 3.5% 2,239,353 -51% 0.43% $15,294,781
PERCEPTIVE ADVISORS LLC 3.2% 2,097,236 0.42% $14,324,122
Point72 Asset Management, L.P. 1.9% 1,208,399 +0.01% 0.02% $8,253,366
Frazier Life Sciences Management, L.P. 1.8% 1,157,380 0.24% $7,904,905
FRANKLIN RESOURCES INC 1.6% 1,038,000 0% 0% $7,089,540
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.5% 1,000,000 0% 0.01% $6,830,000
SR One Capital Management, LP 1.2% 747,750 0% 0.74% $5,107,133
BANK OF AMERICA CORP /DE/ 1% 647,192 -68% 0% $4,420,321
MPM BIOIMPACT LLC 0.82% 530,299 0.59% $3,621,942
Omega Fund Management, LLC 0.82% 526,357 0% 1.6% $3,595,018
SPHERA FUNDS MANAGEMENT LTD. 0.78% 504,409 0% 0.82% $3,445,113
MORGAN STANLEY 0.67% 435,291 +23% 0% $2,973,037
Vestal Point Capital, LP 0.57% 370,000 0% 0.11% $2,527,100
MARSHALL WACE, LLP 0.53% 343,928 0% 0% $2,349,028
GOLDMAN SACHS GROUP INC 0.23% 147,602 -84% 0% $1,008,122
Affinity Asset Advisors, LLC 0.12% 77,000 0% 0.05% $525,910
CITADEL ADVISORS LLC 0.09% 58,370 +153% 0% $398,667
NORTHERN TRUST CORP 0.05% 30,295 -8.3% 0% $206,915
GEODE CAPITAL MANAGEMENT, LLC 0.04% 29,018 0% 0% $198,192

Institutional Holders of enGene Holdings Inc. - Common Shares (ENGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 40,868,497 $279,131,773 +$5,402,489 683% 38
2025 Q2 40,420,485 $147,130,372 -$1,920,470 364% 37
2025 Q1 40,941,351 $183,416,794 -$6,334,706 448% 31
2024 Q4 41,304,528 $274,675,480 +$47,869,542 665% 34
2024 Q3 34,293,391 $227,693,885 +$6,723,051 660% 30
2024 Q2 32,608,601 $307,109,469 -$7,912,013 943% 30
2024 Q1 31,657,538 $536,055,932 +$295,887,521 1,695% 31
2023 Q4 14,187,864 $130,941,207 +$50,843,719 923% 11